Detection of latent tuberculosis infection in peritoneal dialysis patients: New methods;Detección de la infección tuberculosa latente en pacientes en diálisis peritoneal: Nuevos métodos

Nefrologia

Volumn 31, Issue 2, 2011, Pages 169-173

  Palomar Fontanet, R ^a   Arias Guillen M ^b   Robledo, C ^a   Aguero R ^c   Aguero J ^c   Rodriguez C ^b   Molinos, L ^b   Rodrigo, E ^a   Ortega, F ^b   Arias, M ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Chronic renal failure; Peritoneal dialisis; QuantiferonTB gold in tube; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LABORATORY DIAGNOSIS; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; RADIOGRAPHY; RISK; SECRETION; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

ADULT; AGED; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; LATENT TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MALE; MASS SCREENING; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; RISK; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 79954519519     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Jan.10765     Document Type: Article

References (17)

1. Sester U, Junker H, Hodapp T, et al. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 2006;21:3258-62.
2. Wauters A, Peetermans WE, Van der Brande P, et al. The value of tuberculin skin testing in hemodialysis patients. Nephrol Dial Transplant 2004;19:433-8.
3. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004;65:1826-34.
4. Torres HE, Zapico M, Vivas S, et al. Aplicación clínica de una prueba de producción de interferón gamma para el diagnóstico de tuberculosis latente en poblaciones hospitalarias de riesgo. Med Clin (Barc) 2008;130(20):761-6.
5. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007;7:2797-801.
6. Winthrop KL, Daley CL. A novel assay for screening patients for latent tuberculosis infection prior to anti-THF therapy. Nature Clin Prac 2008;4(9):456-7.
7. Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 2010;10:7.
8. Woeltje KF, Mathew A, Rothstein M, Seiler S and Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998; 31: 848-52.
9. U.S. Renal Data System. 1999 Annual Data Report. Am J Kidney Dis 1999;34:S9-S19.
10. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996;16:183-91.
11. González-Gutiérrez M, De Francisco ALM, Sanz S, et al. Interleukin-2 deficit in hemodialysis patients. Role of prostaglandins. Renal Faiure 1992;14(4):563-9.
12. Fernández-Fresnedo G, Ramos MA, González-Pardo MC, et al. B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 2000;15:502-10.
13. Smirnoff M, Patt C, Seckler B, et al. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998;113:25-7.
14. Grindt M, Sester U, Sester M, et al. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999;14:2807-10.
15. Meuer SC, Hauer M, Kurz P, et al. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987;80:743-9.
16. Passalent L, Khan K, Richardson R, et al. Detecting latent tuberculosis infection in Hemodialysis patients: a head-to head comparison of the T-SPOTTB test, tuberculin skin test, and an expert physician panel. J Am Soc Nephrol 2007;2:68-73.
17. http://www.senefro.org.